# Restorelle® Mesh Versus Native Tissue Repair for Prolapse

> **NCT02162615** · — · COMPLETED · sponsor: **Coloplast A/S** · enrollment: 810 (actual)

## Conditions studied

- Pelvic Organ Prolapse

## Interventions

- **DEVICE:** Restorelle Direct Fix A
- **DEVICE:** Restorelle Direct Fix P
- **PROCEDURE:** Native Tissue Repair Anterior
- **PROCEDURE:** Native Tissue Repair Posterior

## Key facts

- **NCT ID:** NCT02162615
- **Lead sponsor:** Coloplast A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2020-01-15
- **Final completion:** 2021-11-06
- **Target enrollment:** 810 (ACTUAL)
- **Last updated:** 2022-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02162615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02162615, "Restorelle® Mesh Versus Native Tissue Repair for Prolapse". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02162615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*